High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection

被引:28
作者
Arora, V.
Kachroo, S. [2 ]
Ghantoji, S. S. [2 ]
DuPont, H. L. [2 ,3 ,4 ]
Garey, K. W. [1 ,2 ,3 ]
机构
[1] Univ Houston, Coll Pharm, Dept Clin Sci & Adm, Houston, TX 77030 USA
[2] Univ Texas Sch Publ Hlth, Houston, TX USA
[3] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[4] Baylor Coll Med, Houston, TX 77030 USA
关键词
Clostridium difficile; Horn's index; Prospective study; Infection control; Outcomes; HOSPITALIZED-PATIENTS; UNITED-STATES; RISK-FACTORS; DISEASE; DIARRHEA; SEVERITY; EPIDEMIC; BURDEN; STRAIN; COSTS;
D O I
10.1016/j.jhin.2011.04.027
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Several variables have been proposed to predict the prognosis of patients with Clostridium difficile infection (CDI), but a clinically useful tool to stratify resource utilization has not been determined. Horn's index, a severity score based on underlying clinical illness, reliably predicts patients at high risk of CDI. The purpose of this study was to assess the use of Horn's index to stratify patients with CDI at high risk of poor clinical and economic outcomes. Hospitalized patients diagnosed with CDI were followed prospectively for three months. Horn's index scores were calculated for each patient on the day of the positive toxin test for C. difficile, and used to stratify differences in outcome variables (length of hospital stay, mortality and hospital costs). Eighty-five CDI patients (50% male, 64% Caucasian) were recruited. Discharge mortality was 0% for patients with Horn's index scores of 1 or 2, 5% for those with a score of 3, and 50% for those with a score of 4 (P < 0.001). Three-month mortality was 0%, 5%, 17% and 60% for patients with Horn's index scores of 1, 2, 3 and 4, respectively (P = 0.0004). Median three-month hospital costs were $8585, $12,670, $29,077 and $68,708 for patients with Horn's index scores of 1, 2, 3 and 4, respectively (P < 0.001). Patients with Horn's index scores of 3 or 4 had a significantly longer hospital stay [mean 33.4 (standard deviation, SD 33.3) days] than patients with scores of 1 or 2 [mean 15.1 (SD 16.2) days, P = 0.001]. This study found Horn's index to be a simple and useful method for identifying CDI patients at high risk of poor clinical and economic outcomes. (C) 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:23 / 26
页数:4
相关论文
共 21 条
[1]  
Al-Eidan FA, 2000, J CLIN PHARM THER, V25, P101
[2]   Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 [J].
Archibald, LK ;
Banerjee, SN ;
Jarvis, WR .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (09) :1585-1589
[3]   Short- and long-term attributable costs of Clostridium difficile -: Associated disease in nonsurgical inpatients [J].
Dubberke, Erik R. ;
Reske, Kimberly A. ;
Olsen, Margaret A. ;
McDonald, L. Clifford ;
Fraser, Victoria J. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (04) :497-504
[4]   Review of Current Literature on the Economic Burden of Clostridium difficile Infection [J].
Dubberke, Erik R. ;
Wertheimer, Albert I. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (01) :57-66
[5]   Meta-analysis to assess risk factors for recurrent Clostridium difficile infection [J].
Garey, K. W. ;
Sethi, S. ;
Yadav, Y. ;
DuPont, H. L. .
JOURNAL OF HOSPITAL INFECTION, 2008, 70 (04) :298-304
[6]   Economic healthcare costs of Clostridium difficile infection: a systematic review [J].
Ghantoji, S. S. ;
Sail, K. ;
Lairson, D. R. ;
DuPont, H. L. ;
Garey, K. W. .
JOURNAL OF HOSPITAL INFECTION, 2010, 74 (04) :309-318
[7]   MEASURING SEVERITY OF ILLNESS - HOMOGENEOUS CASE MIX GROUPS [J].
HORN, SD ;
SHARKEY, PD ;
BERTRAM, DA .
MEDICAL CARE, 1983, 21 (01) :14-30
[8]   Prospective Derivation and Validation of a Clinical Prediction Rule for Recurrent Clostridium difficile Infection [J].
Hu, Mary Y. ;
Katchar, Kianoosh ;
Kyne, Lorraine ;
Maroo, Seema ;
Tummala, Sanjeev ;
Dreisbach, Valley ;
Xu, Hua ;
Leffler, Daniel A. ;
Kelly, Ciaran P. .
GASTROENTEROLOGY, 2009, 136 (04) :1206-1214
[9]  
Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500
[10]   Emergence of Clostridium difficile-associated disease in North America and Europe [J].
Kuijper, E. J. ;
Coignard, B. ;
Tull, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :2-18